• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补充锌对 5/6 肾切除大鼠肾性贫血的影响,并与重组人红细胞生成素治疗进行比较。

Effect of Zinc Supplementation on Renal Anemia in 5/6-Nephrectomized Rats and a Comparison with Treatment with Recombinant Human Erythropoietin.

机构信息

Department of Food Science, College of Life Sciences, National Taiwan Ocean University, Keelung 20224, Taiwan.

Department of Basic Medicine, The Center of Translational Medicine, Xiamen Medical College, Xiamen 361023, China.

出版信息

Int J Mol Sci. 2019 Oct 9;20(20):4985. doi: 10.3390/ijms20204985.

DOI:10.3390/ijms20204985
PMID:31600973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6829362/
Abstract

Anemia is a severe complication in patients with chronic kidney disease (CKD). Treatment with exogenous erythropoietin (EPO) can correct anemia in many with CKD. We produced 5/6-nephrectomized rats that became uremic and anemic at 25 days post surgery. Injection of the anemic 5/6-nephrectomized rats with 2.8 mg zinc/kg body weight raised their red blood cell (RBC) levels from approximately 85% of the control to 95% in one day and continued for 4 days. We compared the effect of ZnSO and recombinant human erythropoietin (rHuEPO) injections on relieving anemia in 5/6-nephrectomized rats. After three consecutive injections, both the ZnSO and rHuEPO groups had significantly higher RBC levels (98 ± 6% and 102 ± 6% of the control) than the saline group (90 ± 3% of the control). In vivo, zinc relieved anemia in 5/6-nephrectomized rats similar to rHuEPO. In vitro, we cultured rat bone marrow cells supplemented with ZnCl, rHuEPO, or saline. In a 4-day suspension culture, we found that zinc induced erythropoiesis similar to rHuEPO. When rat bone marrow cells were supplement-cultured with zinc, we found that zinc stimulated the production of EPO in the culture medium and that the level of EPO produced was dependent on the concentration of zinc supplemented. The production of EPO via zinc supplementation was involved in the process of erythropoiesis.

摘要

贫血是慢性肾脏病(CKD)患者的严重并发症。用外源性促红细胞生成素(EPO)治疗可以纠正许多 CKD 患者的贫血。我们制作了 5/6 肾切除术大鼠,这些大鼠在手术后 25 天变成尿毒症和贫血。给贫血的 5/6 肾切除术大鼠注射 2.8 毫克/公斤体重的锌,可使红细胞(RBC)水平在一天内从对照组的约 85%提高到 95%,并持续 4 天。我们比较了 ZnSO 和重组人促红细胞生成素(rHuEPO)注射对缓解 5/6 肾切除术大鼠贫血的影响。连续三次注射后,ZnSO 和 rHuEPO 组的 RBC 水平均明显高于对照组(分别为对照组的 98±6%和 102±6%),而生理盐水组仅为对照组的 90±3%。在体内,锌与 rHuEPO 一样可缓解 5/6 肾切除大鼠的贫血。在体外,我们培养补充 ZnCl、rHuEPO 或生理盐水的大鼠骨髓细胞。在为期 4 天的悬浮培养中,我们发现锌诱导红细胞生成的作用与 rHuEPO 相似。当大鼠骨髓细胞补充锌培养时,我们发现锌刺激培养基中 EPO 的产生,并且产生的 EPO 水平取决于补充的锌浓度。通过补充锌产生 EPO 参与了红细胞生成过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/34ad9d09be28/ijms-20-04985-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/b4f16b7b2118/ijms-20-04985-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/988385dae9cd/ijms-20-04985-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/4a62600bf738/ijms-20-04985-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/a8aeffaf4cd7/ijms-20-04985-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/182cb22f7066/ijms-20-04985-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/354184a18eac/ijms-20-04985-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/db9729078c97/ijms-20-04985-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/34ad9d09be28/ijms-20-04985-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/b4f16b7b2118/ijms-20-04985-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/988385dae9cd/ijms-20-04985-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/4a62600bf738/ijms-20-04985-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/a8aeffaf4cd7/ijms-20-04985-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/182cb22f7066/ijms-20-04985-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/354184a18eac/ijms-20-04985-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/db9729078c97/ijms-20-04985-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338b/6829362/34ad9d09be28/ijms-20-04985-g008.jpg

相似文献

1
Effect of Zinc Supplementation on Renal Anemia in 5/6-Nephrectomized Rats and a Comparison with Treatment with Recombinant Human Erythropoietin.补充锌对 5/6 肾切除大鼠肾性贫血的影响,并与重组人红细胞生成素治疗进行比较。
Int J Mol Sci. 2019 Oct 9;20(20):4985. doi: 10.3390/ijms20204985.
2
Response to erythropoietin in pediatric patients with chronic kidney disease: insights from an in vitro bioassay.儿童慢性肾脏病患者对促红细胞生成素的反应:体外生物测定的见解。
Pediatr Nephrol. 2018 Nov;33(11):2123-2129. doi: 10.1007/s00467-018-4016-1. Epub 2018 Jul 20.
3
The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.缺氧诱导因子/促红细胞生成素(EPO)/EPO 受体通路在慢性肾脏病相关贫血的大鼠模型中受到干扰。
PLoS One. 2018 May 8;13(5):e0196684. doi: 10.1371/journal.pone.0196684. eCollection 2018.
4
Zinc Supplementation Stimulates Red Blood Cell Formation in Rats.补锌可刺激大鼠红细胞生成。
Int J Mol Sci. 2018 Sep 18;19(9):2824. doi: 10.3390/ijms19092824.
5
Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia.重组人促红细胞生成素强化治疗停止后会继发贫血。
Blood. 2001 Jan 15;97(2):442-8. doi: 10.1182/blood.v97.2.442.
6
Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia.慢性肾脏病相关性贫血大鼠模型中对重组人促红细胞生成素治疗的抵抗性
Int J Mol Sci. 2015 Dec 25;17(1):28. doi: 10.3390/ijms17010028.
7
Oral Zinc-Rich Oyster Supplementation Corrects Anemia in Rats.口服富含锌的牡蛎补充剂可纠正大鼠贫血。
Nutrients. 2023 Nov 4;15(21):4675. doi: 10.3390/nu15214675.
8
Improvement of anemia in W/WV mice by recombinant human erythropoietin (rHuEPO) mediated through EPO receptors with lowered affinity.重组人促红细胞生成素(rHuEPO)通过亲和力降低的促红细胞生成素受体介导改善W/WV小鼠的贫血状况。
Life Sci. 1995;57(11):1067-76. doi: 10.1016/0024-3205(95)02052-k.
9
Renal anemia: from incurable to curable.肾性贫血:从不可治愈到可治愈。
Am J Physiol Renal Physiol. 2013 Nov 1;305(9):F1239-48. doi: 10.1152/ajprenal.00233.2013. Epub 2013 Jul 24.
10
JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat.JTZ-951(恩那司他),一种低氧诱导因子脯氨酰羟化酶抑制剂,改善炎症中铁的利用和贫血:与重组红细胞生成素在大鼠中的比较研究。
Eur J Pharmacol. 2021 May 5;898:173990. doi: 10.1016/j.ejphar.2021.173990. Epub 2021 Feb 28.

引用本文的文献

1
Zinc Deficiency in Chronic Kidney Disease and Hemodialysis: Insights from Basic Research to Clinical Implications.慢性肾脏病和血液透析中的锌缺乏:从基础研究到临床意义的见解
Nutrients. 2025 Jun 30;17(13):2191. doi: 10.3390/nu17132191.
2
Lyophilized powder of calf bone marrow hydrolysate liposomes improved renal anemia: In vitro and in vivo evaluation.冻干小牛骨髓水解物脂质体粉末改善肾性贫血:体内外评价
PLoS One. 2024 Dec 26;19(12):e0314811. doi: 10.1371/journal.pone.0314811. eCollection 2024.
3
Identification of independent risk factors for hypoalbuminemia in patients with CKD stages 3 and 4: the construction of a nomogram.

本文引用的文献

1
Zinc Supplementation Stimulates Red Blood Cell Formation in Rats.补锌可刺激大鼠红细胞生成。
Int J Mol Sci. 2018 Sep 18;19(9):2824. doi: 10.3390/ijms19092824.
2
A review of select minerals influencing the haematopoietic process.选择影响造血过程的矿物质综述。
Nutr Res Rev. 2018 Dec;31(2):267-280. doi: 10.1017/S0954422418000112. Epub 2018 Jul 9.
3
Effect of Zinc Supplementation on Maintenance Hemodialysis Patients: A Systematic Review and Meta-Analysis of 15 Randomized Controlled Trials.补锌对维持性血液透析患者的影响:15 项随机对照试验的系统评价和荟萃分析。
慢性肾脏病3期和4期患者低白蛋白血症独立危险因素的识别:列线图的构建
Front Nutr. 2024 Oct 31;11:1453240. doi: 10.3389/fnut.2024.1453240. eCollection 2024.
4
Zinc deficiency induces hypertension by paradoxically amplifying salt sensitivity under high salt intake in mice.缺锌通过在高盐摄入下反常地放大盐敏感性而导致高血压。
Clin Exp Nephrol. 2024 Aug;28(8):728-739. doi: 10.1007/s10157-024-02478-7. Epub 2024 Apr 6.
5
Oral Zinc-Rich Oyster Supplementation Corrects Anemia in Rats.口服富含锌的牡蛎补充剂可纠正大鼠贫血。
Nutrients. 2023 Nov 4;15(21):4675. doi: 10.3390/nu15214675.
6
Benefits and risks of essential trace elements in chronic kidney disease: a narrative review.慢性肾脏病中必需微量元素的益处与风险:一项叙述性综述
Ann Transl Med. 2022 Dec;10(24):1400. doi: 10.21037/atm-22-5969.
7
Association of Zinc with Anemia.锌与贫血的关系。
Nutrients. 2022 Nov 20;14(22):4918. doi: 10.3390/nu14224918.
8
Effects of Zinc Acetate Hydrate Supplementation on Renal Anemia with Hypozincemia in Hemodialysis Patients.醋酸锌水合物补充对血液透析患者低血锌肾性贫血的影响。
Toxins (Basel). 2022 Oct 31;14(11):746. doi: 10.3390/toxins14110746.
9
Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patients.血清痕量金属与新发病例和维持性血液透析患者对红细胞生成刺激剂反应的关系。
Sci Rep. 2020 Nov 19;10(1):20202. doi: 10.1038/s41598-020-77311-8.
Biomed Res Int. 2017;2017:1024769. doi: 10.1155/2017/1024769. Epub 2017 Dec 31.
4
Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.口服补充锌可降低血液透析患者的促红细胞生成素反应指数。
Nutrients. 2015 May 15;7(5):3783-95. doi: 10.3390/nu7053783.
5
Trace element supplementation in hemodialysis patients: a randomized controlled trial.血液透析患者的微量元素补充:一项随机对照试验。
BMC Nephrol. 2015 Apr 11;16:52. doi: 10.1186/s12882-015-0042-4.
6
Effects of zinc supplementation on serum zinc and leptin levels, BMI, and body composition in hemodialysis patients.补锌对血液透析患者血清锌和瘦素水平、BMI 及身体成分的影响。
J Trace Elem Med Biol. 2014 Jan;28(1):35-8. doi: 10.1016/j.jtemb.2013.09.001. Epub 2013 Sep 10.
7
Erythropoietin.促红细胞生成素。
Cold Spring Harb Perspect Med. 2013 Mar 1;3(3):a011619. doi: 10.1101/cshperspect.a011619.
8
Models of chronic kidney disease.慢性肾脏病模型
Drug Discov Today Dis Models. 2010;7(1-2):13-19. doi: 10.1016/j.ddmod.2010.08.002.
9
Trace element status in hemodialysis patients.血液透析患者的微量元素状况
Semin Dial. 2010 Jul-Aug;23(4):389-95. doi: 10.1111/j.1525-139X.2010.00746.x. Epub 2010 Jun 14.
10
Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients.维持性血液透析患者的锌缺乏性贫血及锌治疗的效果
Ther Apher Dial. 2009 Jun;13(3):213-9. doi: 10.1111/j.1744-9987.2009.00656.x.